Evidence map›Paper›PMID 35448863›Full record

ArticleToxins2022

Gambierol Blocks a K

Evelyne Benoit, Sébastien Schlumberger, Jordi Molgó, Makoto Sasaki, Haruhiko Fuwa, Roland Bournaud

Open access · goldAbstract read
In one paragraph

Article in Toxins, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Evelyne BenoitService d'Ingénierie Moléculaire pour la Santé (SIMoS), Département Médicaments et Technologies pour la Santé (DMTS), Institut des Sciences du Vivant Frédéric Joliot, Université Paris-Saclay, CEA, INRAE, ERL CNRS 9004, F-91191 Gif-sur-Yvette, France.ORCID 0000-0001-5501-0888
Sébastien SchlumbergerCNRS, Laboratoire de Neurobiologie Cellulaire et Moléculaire-UPR 9040, F-91198 Gif-sur-Yvette, France.
Jordi MolgóService d'Ingénierie Moléculaire pour la Santé (SIMoS), Département Médicaments et Technologies pour la Santé (DMTS), Institut des Sciences du Vivant Frédéric Joliot, Université Paris-Saclay, CEA, INRAE, ERL CNRS 9004, F-91191 Gif-sur-Yvette, France.ORCID 0000-0002-0693-8994
Makoto SasakiGraduate School of Life Sciences, Tohoku University, Sendai 980-8577, Japan.
Haruhiko FuwaDepartment of Applied Chemistry, Faculty of Science and Engineering, Chuo University, Tokyo 112-8551, Japan.ORCID 0000-0001-5343-9023
Roland BournaudCNRS, Laboratoire de Neurobiologie Cellulaire et Moléculaire-UPR 9040, F-91198 Gif-sur-Yvette, France.
Centre National de la Recherche Scientifique · FRChuo University · JPTohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gambierol inhibits voltage-gated K

Indexed as

Chromaffin CellsCiguatoxinsAdenosine TriphosphateAnimalsCalciumCatecholaminesCells, CulturedOxocinsPotassiumRatsAdenosine TriphosphateCalciumCatecholaminesCiguatoxinsgambierolOxocinsPotassiumATP-sensitive K+ channelscalcium-activated K+ channelscatecholamine releasefetal adrenomedullary chromaffin cellgambierolpotassium currents

Identifiers

PMID35448863
PMCPMC9025636
OpenAlexW4224320417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.